However, in contrast to the findings with CD4+TSCM, comparable level of S1-reactive CD8+TSCM was detected in HCs and participants with type 2 diabetes after both doses (Figure 5E). The gene discussed is CD8A; the disease is type 2 diabetes mellitus.